Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Nov;16(11):860-862.
doi: 10.1016/S1474-4422(17)30331-9. Epub 2017 Sep 25.

Predicting progression in patients with Parkinson's disease

Affiliations
Comment

Predicting progression in patients with Parkinson's disease

Cornelis Blauwendraat et al. Lancet Neurol. 2017 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

References

    1. Latourelle JC, Beste MT, Hadzi TC, et al. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson’s disease: a longitudinal cohort study and validation. Lancet Neurol. 2017 published online Sept 25. http://dx.doi.org/10.1016/S1474-4422(17)30328-9. - DOI - PMC - PubMed
    1. Nalls MA, Keller MF, Hernandez DG, et al. Baseline genetic associations in the Parkinson’s Progression Markers Initiative (PPMI) Mov Disord. 2016;31:79–85. - PMC - PubMed
    1. Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI) Prog Neurobiol. 2011;95:629–35. - PMC - PubMed
    1. Ravina B, Tanner C, Dieuliis D, et al. A longitudinal program for biomarker development in Parkinson’s disease: a feasibility study. Mov Disord. 2009;24:2081–90. - PubMed
    1. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70. - PubMed

Publication types